Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T, Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K, Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M, Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M.

J Infect Chemother. 2019 Sep;25(9):657-668. doi: 10.1016/j.jiac.2019.05.006. Epub 2019 Jun 10.

PMID:
31196772
2.

Publisher Correction: Medusozoan genomes inform the evolution of the jellyfish body plan.

Khalturin K, Shinzato C, Khalturina M, Hamada M, Fujie M, Koyanagi R, Kanda M, Goto H, Anton-Erxleben F, Toyokawa M, Toshino S, Satoh N.

Nat Ecol Evol. 2019 Jun;3(6):989. doi: 10.1038/s41559-019-0905-3.

PMID:
31048744
3.

Medusozoan genomes inform the evolution of the jellyfish body plan.

Khalturin K, Shinzato C, Khalturina M, Hamada M, Fujie M, Koyanagi R, Kanda M, Goto H, Anton-Erxleben F, Toyokawa M, Toshino S, Satoh N.

Nat Ecol Evol. 2019 May;3(5):811-822. doi: 10.1038/s41559-019-0853-y. Epub 2019 Apr 15. Erratum in: Nat Ecol Evol. 2019 Jun;3(6):989.

PMID:
30988488
4.

Laboratory surveillance of antimicrobial resistance and multidrug resistance among Streptococcus pneumoniae isolated in the Kinki region of Japan, 2001-2015.

Toda H, Satoh K, Komatsu M, Fukuda S, Nakamura T, Jikimoto T, Nishio H, Yamasaki K, Maede T, Orita T, Sueyoshi N, Kita M, Toyokawa M, Nishi I, Akagi M, Higuchi T, Kofuku T, Nakai I, Ono T, Shimakawa K, Hikita Y, Moro K, Kida K, Oohama M, Wada Y, Tobe T, Kamisako T, Tanaka Y.

J Infect Chemother. 2018 Mar;24(3):171-176. doi: 10.1016/j.jiac.2017.12.010. Epub 2018 Feb 1.

PMID:
29361416
5.

Evaluation of the FilmArray Blood Culture Identification Panel on Detection of Pathogenic Microorganisms in Positive Blood Cultures: the First Clinical Report in Japan.

Saito K, Endo S, Katsumi M, Ishizawa C, Fujikawa Y, Inomata S, Toyokawa M, Kaku M.

Jpn J Infect Dis. 2018 Mar 22;71(2):145-147. doi: 10.7883/yoken.JJID.2017.414. Epub 2017 Dec 26.

6.

Endogenous Fusarium Endophthalmitis During Treatment for Acute Myeloid Leukemia, Successfully Treated with 25-Gauge Vitrectomy and Antifungal Medications.

Yoshida M, Kiyota N, Maruyama K, Kunikata H, Toyokawa M, Hagiwara S, Makimura K, Sato N, Taniuchi S, Nakazawa T.

Mycopathologia. 2018 Apr;183(2):451-457. doi: 10.1007/s11046-017-0221-x. Epub 2017 Dec 16.

PMID:
29249044
7.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Watanabe A, Aoki N, Matsumoto T, Yoshida M, Sato J, Wakamura T, Sunakawa K, Kadota J, Kiyota H, Iwata S, Kaku M, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Takeuchi K, Takeda H, Ikeda H, Miki M, Nakanowatari S, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Morino E, Takasaki J, Mezaki K, Chonabayashi N, Tanaka C, Sugiura H, Goto H, Saraya T, Kurai D, Katono Y, Inose R, Niki Y, Takuma T, Kudo M, Ehara S, Sato Y, Tsukada H, Watabe N, Honma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Seki M, Hamaguchi S, Toyokawa M, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Nakamura T, Mikasa K, Kasahara K, Ui K, Fukuda S, Nakamura A, Morimura M, Yamashita M, Takesue Y, Wada Y, Sugimoto K, Kusano N, Nose M, Mihara E, Kuwabara M, Doi M, Watanabe Y, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Ota T, Fujita M, Honda J, Hiramatsu K, Aoki Y, Fukuoka M, Magarifuchi H, Nagasawa Z, Kaku N, Fujita J, Higa F, Tateyama M.

J Infect Chemother. 2017 Sep;23(9):587-597. doi: 10.1016/j.jiac.2017.05.010. Epub 2017 Jun 29.

PMID:
28669567
8.

Endophthalmitis associated with Purpureocillium lilacinum during infliximab treatment for surgically induced necrotizing scleritis, successfully treated with 27-gauge vitrectomy.

Yoshida M, Yokokura S, Kunikata H, Takada N, Maruyama K, Toyokawa M, Kashio K, Kaku M, Nakazawa T.

Int Ophthalmol. 2018 Apr;38(2):841-847. doi: 10.1007/s10792-017-0532-4. Epub 2017 Apr 20.

PMID:
28429128
9.

A Chronic Respiratory Pasteurella multocida Infection Is Well-Controlled by Long-Term Macrolide Therapy.

Seki M, Sakata T, Toyokawa M, Nishi I, Tomono K.

Intern Med. 2016;55(3):307-10. doi: 10.2169/internalmedicine.55.4929. Epub 2016 Feb 1.

10.

Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains?

Senoh M, Kato H, Fukuda T, Niikawa A, Hori Y, Hagiya H, Ito Y, Miki H, Abe Y, Furuta K, Takeuchi H, Tajima H, Tominaga H, Satomura H, Kato H, Morita S, Tanada A, Hara T, Kawada M, Sato Y, Takahashi M, Higuchi A, Nakajima T, Wakamatsu Y, Toyokawa M, Ueda A, Roberts P, Miyajima F, Shibayama K.

J Med Microbiol. 2015 Oct;64(10):1226-36. doi: 10.1099/jmm.0.000149. Epub 2015 Jul 31.

PMID:
26238868
11.

Validation of a phage-open reading frame typing kit for rapid identification of methicillin-resistant Staphylococcus aureus (MRSA) transmission in a tertiary hospital.

Takahashi H, Seki M, Yamamoto N, Hamaguchi S, Ojima M, Hirose T, Yoshiya K, Toyokawa M, Nishi I, Ogura H, Shimazu T, Tomono K.

Infect Drug Resist. 2015 May 14;8:107-11. doi: 10.2147/IDR.S83509. eCollection 2015.

12.

Invasive pulmonary aspergillosis due to Aspergillus lentulus: Successful treatment of a liver transplant patient.

Yoshida H, Seki M, Umeyama T, Urai M, Kinjo Y, Nishi I, Toyokawa M, Kaneko Y, Ohno H, Miyazaki Y, Tomono K.

J Infect Chemother. 2015 Jun;21(6):479-81. doi: 10.1016/j.jiac.2015.02.010. Epub 2015 Mar 6.

PMID:
25828927
13.

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptibility.

Yanagihara K, Kadota J, Aoki N, Matsumoto T, Yoshida M, Yagisawa M, Oguri T, Sato J, Ogasawara K, Wakamura T, Sunakawa K, Watanabe A, Iwata S, Kaku M, Hanaki H, Ohsaki Y, Watari T, Toyoshima E, Takeuchi K, Shiokoshi M, Takeda H, Miki M, Kumagai T, Nakanowatari S, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Kobayashi N, Takasaki J, Mezaki K, Konosaki H, Aoki Y, Yamamoto Y, Shoji M, Goto H, Saraya T, Kurai D, Okazaki M, Niki Y, Yoshida K, Kawana A, Saionji K, Fujikura Y, Miyazawa N, Kudo M, Sato Y, Yamamoto M, Yoshida T, Nakamura M, Tsukada H, Imai Y, Tsukada A, Kawasaki S, Honma Y, Yamamoto T, Ban N, Mikamo H, Sawamura H, Miyara T, Toda H, Sato K, Nakamura T, Fujikawa Y, Mitsuno N, Mikasa K, Kasahara K, Sano R, Sugimoto K, Asari S, Nishi I, Toyokawa M, Miyashita N, Koguchi Y, Kusano N, Mihara E, Kuwabara M, Watanabe Y, Kawasaki Y, Takeda K, Tokuyasu H, Masui K, Negayama K, Hiramatsu K, Aoki Y, Fukuoka M, Magarifuchi H, Nagasawa Z, Suga M, Muranaka H, Morinaga Y, Honda J, Fujita M.

J Infect Chemother. 2015 Jun;21(6):410-20. doi: 10.1016/j.jiac.2015.02.008. Epub 2015 Feb 28.

14.

In vitro evaluations of topical agents to treat Acanthamoeba keratitis.

Sunada A, Kimura K, Nishi I, Toyokawa M, Ueda A, Sakata T, Suzuki T, Inoue Y, Ohashi Y, Asari S, Iwatani Y.

Ophthalmology. 2014 Oct;121(10):2059-65. doi: 10.1016/j.ophtha.2014.04.013. Epub 2014 May 29.

PMID:
24880905
15.

Susceptibility of various oral antibacterial agents against extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.

Nakamura T, Komatsu M, Yamasaki K, Fukuda S, Higuchi T, Ono T, Nishio H, Sueyoshi N, Kida K, Satoh K, Toda H, Toyokawa M, Nishi I, Sakamoto M, Akagi M, Mizutani T, Nakai I, Kofuku T, Orita T, Zikimoto T, Natsume S, Wada Y.

J Infect Chemother. 2014 Jan;20(1):48-51. doi: 10.1016/j.jiac.2013.08.004. Epub 2013 Dec 11.

PMID:
24462425
16.

[Laboratory-based surveillance of antibacterial drug-resistant bacteria in the Kinki region].

Toyokawa M, Komatsu M, Wada Y.

Rinsho Byori. 2013 Aug;61(8):715-20. Japanese.

PMID:
24218770
17.

Reliable and reproducible method for rapid identification of Nocardia species by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Toyokawa M, Kimura K, Nishi I, Sunada A, Ueda A, Sakata T, Asari S.

Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 2013;24(1):1-8.

PMID:
24800394
18.

Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.

Kitamura K, Kubota K, Ando M, Takahashi S, Nishijima N, Sugano T, Toyokawa M, Miwa K, Kosaihira S, Noro R, Minegishi Y, Seike M, Yoshimura A, Gemma A.

Cancer Chemother Pharmacol. 2013 Feb;71(2):457-61. doi: 10.1007/s00280-012-2026-4. Epub 2012 Nov 21.

PMID:
23178954
19.

[Antimicrobial susceptibilityof clinical isolates of aerobic gram-negative bacteria in 2008].

Yoshida I, Yamaguchi T, Kudo R, Fuji R, Takahashi C, Oota R, Kaku M, Kunishima H, Okada M, Horikawa Y, Shiotani J, Kino H, Ono Y, Fujita S, Matsuo S, Kono H, Asari S, Toyokawa M, Kusano N, Nose M, Hori T, Tanimoto A, Miyamoto H, Saikawa T, Hiramatsu K, Kohno S, Yanagihara K, Yamane N, Nakasone I, Maki H, Yamano Y.

Jpn J Antibiot. 2012 Feb;65(1):73-96. Japanese.

PMID:
22808694
20.

[Antimicrobial susceptibility of clinical isolates of aerobic gram-positive cocci and anaerobic bacteria in 2008].

Yoshida I, Yamaguchi T, Kudo R, Fuji R, Takahashi C, Oota R, Kaku M, Kunishima H, Okada M, Horikawa Y, Shiotani J, Kino H, Ono Y, Fujita S, Matsuo S, Kono H, Asari S, Toyokawa M, Kusano N, Nose M, Horii T, Tanimoto A, Miyamoto H, Saikawa T, Hiramatsu K, Kohno S, Yanagihara K, Yamane N, Nakasone I, Maki H, Yamano Y.

Jpn J Antibiot. 2012 Feb;65(1):49-72. Japanese.

PMID:
22808693
21.

[Surveillance of antimicrobial activity of Pseudomonas aeruginosa isolated in the Kinki district].

Kofuku T, Orita T, Zikimoto T, Kinoshita S, Yamasaki K, Miyamoto Y, Fukuda S, Nishio H, Sueyoshi N, Moro K, Kida K, Satoh K, Nakamura T, Toyokawa M, Nishi I, Nakai I, Komatsu M, Higuchi T, Ono T, Wada Y.

Jpn J Antibiot. 2011 Dec;64(6):367-81. Japanese.

PMID:
22686007
22.

Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan.

Nakamura T, Komatsu M, Yamasaki K, Fukuda S, Miyamoto Y, Higuchi T, Ono T, Nishio H, Sueyoshi N, Kida K, Satoh K, Toda H, Toyokawa M, Nishi I, Sakamoto M, Akagi M, Nakai I, Kofuku T, Orita T, Wada Y, Zikimoto T, Koike C, Kinoshita S, Hirai I, Takahashi H, Matsuura N, Yamamoto Y.

Am J Clin Pathol. 2012 Apr;137(4):620-6. doi: 10.1309/AJCP48PDVKWQOXEZ.

PMID:
22431539
23.

Local treatment of methicillin-resistant Staphylococcus aureus conjunctivitis with short-term high-concentrated minocycline ointment.

Ikeda E, Inoue T, Asari S, Toyokawa M, Hori Y, Maeda N.

Jpn J Ophthalmol. 2011 Sep;55(5):576-578. doi: 10.1007/s10384-011-0059-6. Epub 2011 Jul 26. No abstract available.

PMID:
21789624
24.

Evaluation of amphotericin B and micafungin combination against clinical isolates of Aspergillus species.

Nishi I, Sunada A, Toyokawa M, Asari S, Iwatani Y.

J Chemother. 2011 Apr;23(2):102-6.

PMID:
21571627
25.

[Antimicrobial susceptibility of clinical isolates of aerobic Gram-negative bacteria in 2006].

Yoshida I, Yamaguchi T, Itoh Y, Tachibana M, Takahashi C, Kaku M, Kanemitsu K, Okada M, Horikawa Y, Shiotani J, Kino H, Ono Y, Baba H, Matsuo S, Asari S, Toyokawa M, Matsuoka K, Kusano N, Nose M, Murase M, Miyamoto H, Saikawa T, Hiramatsu K, Kohno S, Yanagihara K, Yamane N, Nakasone I, Maki H, Yamano Y.

Jpn J Antibiot. 2010 Dec;63(6):457-79. Japanese.

PMID:
21425597
26.

[Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2006].

Yamaguchi T, Yoshida I, Itoh Y, Tachibana M, Takahashi C, Kaku M, Kanemitsu K, Okada M, Horikawa Y, Shiotani J, Kino H, Ono Y, Baba H, Matsuo S, Asari S, Toyokawa M, Matsuoka K, Kusano N, Nose M, Murase M, Miyamoto H, Saikawa T, Hiramatsu K, Kohno S, Yanagihara K, Yamane N, Nakasone I, Maki H, Yamano Y.

Jpn J Antibiot. 2010 Dec;63(6):431-56. Japanese.

PMID:
21425596
27.

[Cytomegalovirus infection].

Toyokawa M, Nishi I, Asari S.

Nihon Rinsho. 2010 Aug;68 Suppl 8:523-30. Review. Japanese. No abstract available.

PMID:
20976927
28.

Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan.

Yamasaki K, Komatsu M, Abe N, Fukuda S, Miyamoto Y, Higuchi T, Ono T, Nishio H, Sueyoshi N, Kida K, Satoh K, Toyokawa M, Nishi I, Sakamoto M, Akagi M, Nakai I, Kofuku T, Orita T, Wada Y, Jikimoto T, Kinoshita S, Miyamoto K, Hirai I, Yamamoto Y.

J Clin Microbiol. 2010 Sep;48(9):3267-73. doi: 10.1128/JCM.02111-09. Epub 2010 Jul 7.

29.

Changes in drug susceptibility and the quinolone-resistance determining region of Staphylococcus epidermidis after administration of fluoroquinolones.

Miyanaga M, Nejima R, Miyai T, Miyata K, Ohashi Y, Inoue Y, Toyokawa M, Asari S.

J Cataract Refract Surg. 2009 Nov;35(11):1970-8. doi: 10.1016/j.jcrs.2009.05.049.

PMID:
19878831
30.

Monte Carlo simulation for evaluation of the efficacy of carbapenems and new quinolones against ESBL-producing Escherichia coli.

Nakamura T, Shimizu C, Kasahara M, Okuda K, Nakata C, Fujimoto H, Okura H, Komatsu M, Shimakawa K, Sueyoshi N, Ura T, Satoh K, Toyokawa M, Wada Y, Orita T, Kofuku T, Yamasaki K, Sakamoto M, Nishio H, Kinoshita S, Takahashi H.

J Infect Chemother. 2009 Feb;15(1):13-7. doi: 10.1007/s10156-008-0656-6. Epub 2009 Mar 12.

PMID:
19280294
31.

In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.

Nishi I, Sunada A, Toyokawa M, Asari S, Iwatani Y.

J Infect Chemother. 2009 Feb;15(1):1-5. doi: 10.1007/s10156-008-0653-9. Epub 2009 Mar 12. Erratum in: J Infect Chemother. 2009 Apr;15(2):123-4.

PMID:
19280292
32.

Preliminary analysis of length and GC content variation in the ribosomal first internal transcribed spacer (ITS1) of marine animals.

Chow S, Ueno Y, Toyokawa M, Oohara I, Takeyama H.

Mar Biotechnol (NY). 2009 May-Jun;11(3):301-6. doi: 10.1007/s10126-008-9153-2. Epub 2008 Oct 21.

PMID:
18937008
33.
34.

[Usefulness of immunological detection of both toxin A and toxin B in stool samples for rapid diagnosis of Clostridium difficile-associated diarrhea].

Toyokawa M, Ueda A, Nishi I, Asari S, Adachi K, Annaka M, Inamatsu T.

Kansenshogaku Zasshi. 2007 Jan;81(1):33-8. Japanese.

PMID:
17338314
35.

[Extended-spectrum-beta-lactamase-producing Proteus mirabilis: laboratory-based surveillance in cooperation with 12 clinical laboratories in the Kinki Region of Japan].

Nakamura T, Komatsu M, Shimakawa K, Sueyoshi N, Satoh K, Toyokawa M, Nishio H, Wada Y, Orita T, Kofuku T, Sakamoto M, Okamoto K, Akagi M, Kinoshita S.

Kansenshogaku Zasshi. 2006 May;80(3):231-7. Japanese.

PMID:
16780129
36.

[Nucleic acid-based testing for cytomegalovirus infection].

Toyokawa M, Nishi I, Asari S.

Nihon Rinsho. 2005 Dec;63 Suppl 12:347-52. Review. Japanese. No abstract available.

PMID:
16416817
37.

[Surveillance of antimicrobial resistance of Streptococcus pneumoniae isolates from the Kinki Region of Japan during 2003/2004. The Surveillance Program of Bacterial Resistance in the Kinki Region of Japan; SBRK].

Satoh K, Sueyoshi N, Komatsu M, Shimakawa K, Toyokawa M, Nishi I, Nishio H, Sakamoto M, Yamashita T, Okamoto K, Nakamura T, Nomura C, Wada Y, Ono T, Orita T, Kinoshita S, Koufuku T.

Jpn J Antibiot. 2005 Jun;58(3):221-30. Japanese.

PMID:
16161751
38.

In vitro activity of beta-lactams and quinolones against AmpC beta-lactamase-producing Escherichia coli.

Yamasaki K, Komatsu M, Shimakawa K, Satoh K, Nishio H, Sueyoshi N, Toyokawa M, Sakamoto M, Higuchi T, Wada Y, Kofuku T, Orita T, Yamashita T, Kinoshita S, Aihara M.

J Infect Chemother. 2005 Feb;11(1):9-13.

PMID:
15729481
39.

Metallo-beta-lactamase-producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan.

Nishio H, Komatsu M, Shibata N, Shimakawa K, Sueyoshi N, Ura T, Satoh K, Toyokawa M, Nakamura T, Wada Y, Orita T, Kofuku T, Yamasaki K, Sakamoto M, Kinoshita S, Aihara M, Arakawa Y.

J Clin Microbiol. 2004 Nov;42(11):5256-63.

40.

Severe Chlamydophila psittaci pneumonia rapidly diagnosed by detection of antigen in sputum with an immunochromatography assay.

Toyokawa M, Kishimoto T, Cai Y, Ogawa M, Shiga S, Nishi I, Hosotsubo H, Horikawa M, Asari S.

J Infect Chemother. 2004 Aug;10(4):245-9.

PMID:
15365868
41.

Pseudomembranous colitis caused by toxin A-negative/toxin B-positive variant strain of Clostridium difficile.

Toyokawa M, Ueda A, Tsukamoto H, Nishi I, Horikawa M, Sunada A, Asari S.

J Infect Chemother. 2003 Dec;9(4):351-4.

PMID:
14691659
42.

Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan.

Asari S, Deguchi M, Tahara K, Taniike M, Toyokawa M, Nishi I, Watanabe M, Iwatani Y, Makimoto K.

Am J Infect Control. 2003 May;31(3):157-62.

PMID:
12734521
43.

In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.

Toyokawa M, Asari S, Nishi I, Horikawa M, Tsukamoto H, Sunada A, Ueda A, Iwatani Y.

J Chemother. 2003 Feb;15(1):31-6.

PMID:
12678411
44.

[Cytomegalovirus infection].

Toyokawa M, Nishi I.

Rinsho Byori. 2002 Nov;Suppl 123:71-8. Review. Japanese.

PMID:
12652793
45.

[Resistance to antimicrobiotics and mutation of PBPs in Streptococcus pneumoniae isolated from Kinki region of Japan].

Satoh K, Komatsu M, Shimakawa K, Ura T, Kinoshita S, Yamasaki K, Nishio H, Washizu R, Yamashita T, Nakamura T, Wada Y, Toyokawa M, Koufuku T, Aihara M.

Kansenshogaku Zasshi. 2002 Apr;76(4):254-62. Japanese.

PMID:
12030023
46.

Dietary n-3 polyunsaturated fatty acid and status of immunocompetent cells involved in innate immunity in female rats.

Sasaki T, Kanke Y, Kudoh K, Nagahashi M, Toyokawa M, Matsuda M, Shimizu J, Takita T.

Ann Nutr Metab. 2000;44(1):38-42.

PMID:
10838465
47.

Dietary docosahexaenoic acid can alter the surface expression of CD4 and CD8 on T cells in peripheral blood.

Sasaki T, Kanke Y, Nagahashi M, Toyokawa M, Matsuda M, Shimizu J, Misawa Y, Takita T.

J Agric Food Chem. 2000 Apr;48(4):1047-9.

PMID:
10775347
48.

[A case of multiple cholesterol polyps of the gallbladder with intermittent jaundice of frequent occurrence].

Matsui Y, Higashino T, Makiura A, Yoshii J, Okuda H, Shiroyama Y, Toyokawa M, Yamamoto K, Mochi T, Matsushita K, Kawamoto H, Iwasawa S, Koizumi M, Honda Y, Yamao J, Noshi H, Takaya A, Okamoto S, Fukui H.

Nihon Shokakibyo Gakkai Zasshi. 1997 May;94(5):376-80. Japanese. No abstract available.

PMID:
9170889
49.

[Examination of the inhibitor to factor VIII in non-haemophilic patient].

Suetomo M, Suehisa E, Nishimura K, Toyokawa M, Toku M, Fushimi R, Amino N, Miyai K, Izumi M, Ohtsuka A, et al.

Rinsho Byori. 1991 Jul;39(7):748-52. Japanese.

PMID:
1920868
50.

Serous cystadenoma of the esophagus.

Tsutsumi M, Mizumoto K, Tsujiuchi T, Maruyama H, Koizumi M, Inagaki T, Toyokawa M, Konishi Y.

Acta Pathol Jpn. 1990 Feb;40(2):153-5.

PMID:
2339602

Supplemental Content

Loading ...
Support Center